Aardvark Therapeutics, Inc. SEC filings

Filings

1. 8-KAardvark Therapeutics, Inc.AARDOct 8

   Aardvark appoints David Zhang to board

   • Appointed on 2026-10-07
   • Dr. Zhang has 25+ years in clinical programs
   • Received $500,000 stock option
2. 3Aardvark Therapeutics, Inc.AARDOct 8

   2 insider filings

   Zhongwei Zhang, new insider at AARD

   Show all 2

   • 3New insider at AARDOct 8
   • 4Insider filing for AARDOct 8

   Zhongwei Zhang, reporting

3. 4Aardvark Therapeutics, Inc.AARDSep 11

   Nelson Sun, insider filing for AARD

   Nelson Sun, reporting

4. 144Aardvark Therapeutics, Inc.AARDSep 11

   Nelson Sun, planned sale of AARD shares

   Nelson Sun, reporting

5. 144Aardvark Therapeutics, Inc.AARDSep 10

   Nelson Sun, planned sale of AARD shares

   Nelson Sun, reporting

6. 4Aardvark Therapeutics, Inc.AARDAug 21

   4 insider filings

   Jeffrey Chi, insider filing for AARD

   Show all 4

   • 4Insider filing for AARDAug 21
   • 4Insider filing for AARDAug 21
   • 4Insider filing for AARDAug 21
   • 4Insider filing for AARDAug 21

   Jeffrey Chi, reporting

7. 8-KAardvark Therapeutics, Inc.AARDAug 17

   Current report

8. 10-QAardvark Therapeutics, Inc.AARDAug 11

   Quarterly report

9. 8-KAardvark Therapeutics, Inc.AARDAug 11

   Current report

10. ARSAardvark Therapeutics, Inc.AARDJul 10

    Annual report to shareholders

11. DEF 14AAardvark Therapeutics, Inc.AARDJul 10

    Proxy statement

12. PRE 14AAardvark Therapeutics, Inc.AARDJun 29

    Preliminary proxy statement

13. 8-KAardvark Therapeutics, Inc.AARDJun 12

    Current report

14. 8-KAardvark Therapeutics, Inc.AARDMay 14

    Current report

15. 10-QAardvark Therapeutics, Inc.AARDMay 7

    Quarterly report

16. 8-KAardvark Therapeutics, Inc.AARDMay 7

    Current report

17. EFFECTAardvark Therapeutics, Inc.AARDApr 6

    Registration declared effective

18. 424B5Aardvark Therapeutics, Inc.AARDApr 3

    Securities offering

19. S-3Aardvark Therapeutics, Inc.AARDMar 23

    Securities offering

20. 10-KAardvark Therapeutics, Inc.AARDMar 23

    Annual report

21. 8-KAardvark Therapeutics, Inc.AARDMar 23

    Current report

22. 8-KAardvark Therapeutics, Inc.AARDFeb 27

    Current report

23. 8-KAardvark Therapeutics, Inc.AARDFeb 12

    Current report

24. 4Aardvark Therapeutics, Inc.AARDFeb 11

    3 insider filings

    Tien-Li Lee, insider filing for AARD

    Show all 3

    • 4Insider filing for AARDFeb 11
    • 4Insider filing for AARDFeb 11
    • 4Insider filing for AARDFeb 11

    Tien-Li Lee, reporting

25. 8-KAardvark Therapeutics, Inc.AARDFeb 10

    Current report

26. 8-KAardvark Therapeutics, Inc.AARDJan 12

    Current report

27. 4Aardvark Therapeutics, Inc.AARDDec 18, 2025

    2 insider filings

    Tien-Li Lee, insider filing for AARD

    Show all 2

    • 4Insider filing for AARDDec 18, 2025
    • 4Insider filing for AARDDec 18, 2025

    Tien-Li Lee, reporting

28. 8-KAardvark Therapeutics, Inc.AARDDec 10, 2025

    Current report

29. 10-QAardvark Therapeutics, Inc.AARDNov 13, 2025

    Aardvark Therapeutics, Inc. (AARD) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.

30. 8-KAardvark Therapeutics, Inc.AARDNov 13, 2025

    Aardvark Therapeutics, Inc. (AARD) announced the resignation of its CEO, effective immediately, due to personal reasons. This unexpected leadership change introduces uncertainty and potential disruption to the company's strategic initiatives and ongoing clinical trials for its…

31. 8-KAardvark Therapeutics, Inc.AARDNov 4, 2025

    Current report

Older filings on EDGAR